Group 1 - The China Securities Regulatory Commission (CSRC) has issued supplementary material requirements for 12 companies, including Focus International, regarding compliance with offshore structure and reverse merger regulations [1][2] - Focus International submitted its listing application to the Hong Kong Stock Exchange on June 26, 2025, with Jianquan Financing Limited as the sole sponsor [1] - The CSRC has requested legal opinions on various compliance aspects, including foreign exchange registration, offshore investment, and tax obligations related to the acquisition of domestic operating entities [1][2] Group 2 - The domestic operating entities, Focus Health and Yuejian Nursing, have not fully paid their registered capital, raising questions about compliance and its impact on the company's operations and debt repayment capabilities [2] - The CSRC is seeking clarification on the pricing basis and compliance of past capital increases and share transfers for the domestic entities, as well as the legality of these transactions [2] - There was a change in control of Yuejian Nursing in May 2022 due to a transfer of shares by two shareholders, and the CSRC is investigating the reasons behind this transfer and any potential shareholding arrangements [2] Group 3 - Focus International primarily engages in the manufacturing and sales of absorbent hygiene products, which are categorized into three types: baby care products, female care products, and adult incontinence products [3] - The company employs a multi-brand strategy to offer a wide range of absorbent hygiene products in China, with brands such as "Cotton Hour," "Focus Baby," and "Baimule" for baby care, and "Weiyue" and "Blue Cotton Flower" for female care [3] - The company is required to disclose the scale of funds raised after the full exercise of the over-allotment option in its prospectus [3]

Group 1 - The China Securities Regulatory Commission (CSRC) has issued supplementary material requirements for 12 companies, focusing on compliance related to offshore structures and reverse mergers for JiaoTian International [1] - JiaoTian International submitted its listing application to the Hong Kong Stock Exchange on June 26, 2025, with Jianquan Financing Co., Ltd. as the sole sponsor [1] - The CSRC has requested JiaoTian International to provide legal opinions on various compliance issues, including foreign exchange registration, offshore investment, and tax obligations related to its offshore structure and acquisitions [2] Group 2 - The CSRC has asked for explanations regarding the registered capital of domestic operating entities JiaoTian Health and Yuejian Nursing, including reasons for unpaid capital and its impact on operational and debt repayment capabilities [2] - The company must clarify the pricing basis and compliance of past capital increases and share transfers for JiaoTian Health and Yuejian Nursing, ensuring that all contributions have been fulfilled [2] - The company is required to disclose the scale of raised funds after fully exercising the over-allotment option, as stated in the prospectus [3] Group 3 - JiaoTian International primarily engages in the manufacturing and sales of absorbent hygiene products, which are categorized into three types: baby care products, female hygiene products, and adult incontinence products [3] - The company employs a multi-brand strategy to offer a wide range of absorbent hygiene products in China, with brands such as "Cotton Hour," "JiaoTian Baby," and "Beimu Le" for baby care, and "Weiyue" and "Blue Cotton Flower" for female hygiene products [3]

Core Viewpoint - Focus International Limited, a manufacturer of disposable hygiene products, has submitted a prospectus to the Hong Kong Stock Exchange for a listing on the main board, amidst a competitive market environment for similar companies [2] Company Overview - Focus International was established in 2014 and initially operated as an OEM for international brands in absorbent hygiene products, later developing its own brands [3] - The company’s product categories include baby care products, feminine care products, and adult incontinence products, while also engaging in hygiene product materials business [3][4] - The company plans to cease its adult incontinence product line by August 2024 to optimize resource allocation and focus on higher growth potential core business segments [3] Financial Performance - Focus International has shown significant growth in operating performance over the past three years, with revenues of 181.24 million RMB, 372.32 million RMB, and 447.05 million RMB for the years 2022, 2023, and 2024 respectively [5][6] - Gross profits for the same years were 35.12 million RMB, 87.59 million RMB, and 122.78 million RMB, indicating a rising gross margin trend of approximately 19.4%, 23.5%, and 27.5% [6] - Net profits also increased significantly, with net income and other comprehensive income of 12.27 million RMB, 39.47 million RMB, and 65.61 million RMB for the respective years [6] Market Position and Strategy - The company benefits from growing consumer demand and a multi-brand strategy that has led to rapid expansion in China [7] - Focus International maintains a processing business that serves both domestic and international markets, primarily in Southeast Asia [4][7] - Despite its growth, the company’s gross margin is lower compared to peers like Hengan International and Sofy International, which have gross margins exceeding 30% [7] Ownership Structure - The company is highly concentrated in ownership, with the founder Zhou Hang and his wife holding a combined 99% of the shares, which may raise governance concerns among institutional investors [8][10] - Zhou Hang, the founder and CEO, is notably young at 35 years old, having started the company at 24 [7][10]

Group 1 - The core viewpoint of the article is that Focus International has submitted its prospectus to the Hong Kong Stock Exchange for an IPO, aiming to raise funds for expansion and operational improvements [1][6] - Focus International was established in 2014 and initially operated as a contract manufacturer of absorbent hygiene products, gradually expanding into its own brand market in China [1] - The company’s product categories include baby care, feminine care, and adult incontinence products, with notable brands such as "All Cotton Hour" and "Weiyue" [1] Group 2 - Revenue growth has been significant, with figures rising from 181 million yuan in 2022 to 372 million yuan in 2023, and projected to reach 447 million yuan in 2024 [1] - Net profit has also shown steady growth, increasing from 12.27 million yuan in 2022 to 65.61 million yuan in 2024, alongside an improving gross margin from 19.4% to 27.5% over the same period [1] - The brand product business has seen remarkable growth, with its revenue share increasing from approximately 7.4% in 2022 to 35.8% in 2024, while the contract manufacturing business accounts for 24.1% of revenue [4] Group 3 - The funds raised from the IPO will be allocated for land acquisition, new production facilities, equipment purchases, marketing activities, and enhancing IT infrastructure [6] - The company is primarily controlled by the Zhou couple, who collectively hold 99% of the shares, with Zhou Hang holding 59.4% and He Shanshan holding 39.6% [4]

Core Viewpoint - The wave of "her economy" is drawing attention to the absorbent hygiene products sector, with Focus International officially submitting its IPO application to the Hong Kong Stock Exchange on June 26, 2023 [1] Company Overview - Focus International, established in 2014, specializes in the manufacturing and sales of absorbent hygiene products, categorized into three types: baby care products, female care products, and adult incontinence products. The company also sells hygiene product materials [1] - The company employs a multi-brand strategy, primarily offering a diverse range of absorbent hygiene products in China, including brands like "Cotton Hour," "Focus Baby," and "Baimule" for baby care, and "Weiyue" and "Blue Cotton" for female care [1] Financial Performance - The company has experienced significant revenue growth, with total revenues projected to reach RMB 1.81 billion, RMB 3.72 billion, and RMB 4.47 billion for the fiscal years 2022 to 2024, respectively, reflecting a compound annual growth rate (CAGR) of 57.2% [2][3] - Net profits for the same period are expected to be approximately RMB 12.27 million, RMB 39.47 million, and RMB 65.61 million, indicating steady growth in both revenue and profit [2][3] - The gross profit margin has also improved, increasing from 19.4% in 2022 to 27.5% in 2024 [2] Business Segmentation - Focus International's operations are divided into three segments: OEM (Original Equipment Manufacturer) business, brand business, and hygiene product materials. The brand business has seen a significant increase, with revenues growing by 865% from RMB 13.47 million in 2022 to RMB 130 million in 2023, driven by digital marketing and increased penetration in e-commerce channels [3][4] - The revenue contribution from the brand business is expected to surpass that of hygiene product materials for the first time in 2024, marking a shift in the company's revenue structure [4] Market Trends - The overall market for disposable hygiene products in China is projected to grow from RMB 1,442 billion in 2020 to RMB 1,517 billion in 2024, with a CAGR of approximately 1.3% [7] - The female hygiene segment is expected to grow significantly, with sales projected to increase from RMB 613 billion in 2020 to RMB 867 billion in 2024, reflecting a CAGR of 9.1% [6][12] - Conversely, the baby care segment is facing a decline, with sales expected to drop from RMB 714 billion in 2020 to RMB 513 billion in 2024, indicating a CAGR of -7.9% [6][12] Production Capacity - Focus International operates eight production lines in Quanzhou, Fujian, with high utilization rates for baby care products (97.2% for baby pull-ups and 90.1% for diapers) [5] - However, the adult incontinence product line shows low utilization at only 15.8%, indicating potential inefficiencies in production capacity [9][11] Strategic Direction - The company's core strategic focus includes capacity restructuring, channel expansion into county-level maternal and infant stores, and brand upgrading, with plans to allocate 50% of IPO proceeds to brand building and 30% to expand production capacity [12][13] - The company aims to increase its female care business revenue to RMB 500 million within three years, while also addressing the underutilization of its adult product lines [12][13]

Core Viewpoint - Shubao International (02569) has gained significant attention in the Hong Kong capital market, with its stock price rising 110% from the IPO price of HKD 0.51 to HKD 1.07, resulting in a market capitalization of approximately HKD 1.07 billion [2] Group 1: Stock Performance - The stock experienced a "four rises and four falls" pattern since its listing, indicating volatility in its trading performance [3] - In the first phase from March 27 to April 24, the stock achieved a 48.98% increase over 18 trading days, with a peak rise of over 56% on the first trading day [4][5] - The second phase from April 28 to May 15 saw a 25.71% increase over 12 trading days, with signs of increased control by mainstream funds as the average daily trading volume decreased [7] - The third phase from May 16 to May 28 showed no net change in stock price despite fluctuations, indicating a strategy to attract new investments while maintaining control [9] - The fourth phase from May 29 to June 9 resulted in a 28.41% increase, with a further decrease in trading volume and turnover rate, suggesting deeper control by mainstream funds [11] Group 2: Company Overview - Shubao International, established in 2010 and headquartered in Fujian, specializes in the research, production, and sales of disposable hygiene products, focusing on baby care, women's care, and adult incontinence [14] - The company is the second-largest exporter of disposable baby care products to Russia, holding a market share of approximately 3.7% in 2023 [14] - In 2024, Shubao International reported revenue of approximately CNY 753 million, a year-on-year increase of 15.01%, although growth has slowed compared to previous years [14] - The baby care segment remains the primary revenue driver, contributing CNY 468 million in 2023, with over CNY 300 million from the Russian market [14] Group 3: Market Potential - The women's care segment is showing growth potential, with the company targeting lower-tier markets through platforms like Pinduoduo and Douyin, achieving a 37% repurchase rate for its menstrual pants [15] - The global women's hygiene products market is projected to reach approximately USD 89.29 billion by 2033, with a compound annual growth rate of about 7.8% from 2024 to 2033 [15] - The adult incontinence market presents significant opportunities, with over 42 million individuals aged 60 and above in China affected, yet the market penetration remains below 5% [16] - Shubao International's strategic focus on emerging consumer segments aligns with current market preferences for high-growth stocks in the Hong Kong market [16]

Investment Rating - The report maintains a "Buy" rating for the company with a target price not specified [5] Core Views - The company is leveraging both its proprietary brand and ODM (Original Design Manufacturer) model to drive growth, focusing on expanding into new markets, products, and fields [2] - The company is upgrading its product offerings, particularly in the adult incontinence segment, to cater to a broader demographic, including elderly and postpartum women, with a new medical-grade cranberry probiotic absorbent pad set to launch in March 2025 [2] - The company is enhancing its user engagement through various channels, including offline promotions and community projects, to build a valuable user operation system [3] - The financial forecast has been adjusted, projecting revenues of 1.14 billion, 1.22 billion, and 1.35 billion for 2025, 2026, and 2027 respectively, with net profits expected to be 0.34 billion, 0.37 billion, and 0.42 billion [4] Financial Performance Summary - In Q1 2025, the company reported revenue of 300 million, a decrease of 1% year-on-year, while net profit attributable to the parent company was 20 million, an increase of 1.4% [1] - For 2024, the company anticipates revenue of 1.1 billion, a decrease of 0.3%, and net profit of 30 million, an increase of 54% [1] - The breakdown of revenue by product for 2024 shows adult incontinence products at 560 million (down 1%), baby products at 400 million (up 7%), and pet hygiene products at 70 million (down 22%) [1] - The company’s gross margin for adult incontinence products is projected to be 19.4%, baby products at 21%, and pet hygiene products at 22% [1] Market and Product Strategy - The company is focusing on product differentiation and brand strategy for adult incontinence care products, with plans for smart development in high-end products and optimization in mid-to-low-end products [2] - The company aims to educate users about welfare products through targeted marketing and community engagement [3]